Jevtana and Cardiac arrest - a phase IV clinical study of FDA data

Summary:

Cardiac arrest is reported as a side effect among people who take Jevtana (cabazitaxel), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Polaramine, and have Prostate cancer.

The phase IV clinical study analyzes which people have Cardiac arrest when taking Jevtana. It is created by eHealthMe based on reports of 1,808 people who have side effects when taking Jevtana from the FDA, and is updated regularly.

What is Jevtana?

Jevtana has active ingredients of cabazitaxel. eHealthMe is studying from 1,811 Jevtana users. Check the latest studies of Jevtana.

What is Cardiac arrest?

Cardiac arrest is found to be associated with 2,233 drugs and 2,512 conditions by eHealthMe. Check the latest studies of Cardiac arrest.

On Jul, 19, 2026

1,808 people reported to have side effects when taking Jevtana.
Among them, 20 people (1.11%) have Cardiac arrest.

Among these 20 people:

How long have people been on Jevtana when they have Cardiac arrest? *

What is the gender of people who have Cardiac arrest when taking Jevtana? *

female: 0.0 %
male: 100 %

What is the age of people who have Cardiac arrest when taking Jevtana? *

What are other drugs people take besides Jevtana? *

Decadron: 3 people, 15.00%
Polaramine: 3 people, 15.00%
Prednisolone: 2 people, 10.00%
Neurontin: 2 people, 10.00%
Rozerem: 2 people, 10.00%
Coreg: 2 people, 10.00%
Prednisone: 2 people, 10.00%
Zometa: 1 person, 5.00%
Granisetron Hydrochloride: 1 person, 5.00%
Glipizide: 1 person, 5.00%

What are other side effects people have besides Cardiac arrest? *

Fever: 7 people, 35.00%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 30.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 25.00%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 25.00%
Hypotension (abnormally low blood pressure): 5 people, 25.00%
White Blood Cell Count Decreased: 5 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 20.00%
Breathing - Slowed Or Stopped: 4 people, 20.00%
Dyspnea (difficult or laboured breathing): 4 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 15.00%

What are the existing conditions these people have? *

Prostate Cancer: 12 people, 60.00%
Tongue Neoplasm Malignant Stage Unspecified: 1 person, 5.00%
High Blood Cholesterol: 1 person, 5.00%
Cancer Pain: 1 person, 5.00%
Constipation: 1 person, 5.00%
Diabetes: 1 person, 5.00%
Diarrhea: 1 person, 5.00%
Dry Eye Syndrome: 1 person, 5.00%
Enlarged Prostate: 1 person, 5.00%
Gout (uric acid crystals building up in the body): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Jevtana and have Cardiac arrest?

- Check whether Cardiac arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jevtana:

Jevtana (1,811 reports)

Cardiac arrest treatments and more:

Cardiac arrest (101,931 reports)

Browse all side effects of Jevtana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac arrest:

Cardiac arrest (2,233 drugs)

Browse all the conditions that are associated with Cardiac arrest:

Cardiac arrest (2,512 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabazitaxel (the active ingredients of Jevtana) and Jevtana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.